@cvrg.bsky.social
CardioVascular Resource Group is dedicated to delivering best-in-class Cardiovascular and Metabolic market research and competitive intelligence reports.
CVrg has released our latest CKD Insights report, with the spotlight on IgA Nephropathy (IgAN)—one of the most rapidly evolving areas in chronic kidney disease.
Want to see the full picture?
Request a sample: cv-rg.com/marketinsigh...
#CKD #IgAN #ASN2025 #kidneydiseases
CVrg is excited to attend Pharma CI USA, Sept 17–18 in NJ! If you’re attending, we’d love the opportunity to meet and share more about CVrg’s offerings and how we support strategic decision-making.
#PharmaCI2025 #Biotech #CompetitiveIntelligence #CompetitiveStrategy #CVrg
Our CVrg team will be on the ground at EASD 2025 analyzing the latest data in diabetes, obesity, and the risk factors associated with metabolic diseases.
CVrg's EASD 2025 Coverage: cv-rg.com/conferences/...
#EASD2025 #Cardiovascular #Metabolic #Obesity #Diabetes #CompetitiveStrategy
🚨 Countdown to #ESC2025: August 29!
CVrg's ASCVD lead, Chung I Choi, will be paying close attention to the hot areas of Lp(a) and inflammation in anticipation of Phase III trial readouts next year.
#ESC2025 #Cardiovascular #Metabolic #ASCVD #CompetitiveStrategy #MedicalIntelligence #CVrg
🚨 Countdown to #ESC2025: August 29!
The Hot Line 2 session is already shaping up to be one of the most anticipated.
👉 We’d value your perspective—Take our CVrg ESC Poll www.linkedin.com/feed/update/...
#ESC2025 #Cardiovascular #Metabolic #CompetitiveStrategy #MedicalIntelligence #CVrg
